The Details...
Reporting to the Associate Director, Biologics Production, the successful candidate will carry out the day to day production of kit and flowcell components including, purification of proteins, production of DNA/RNA analytes, production of protein-DNA complexes, production of Triblock components and production of other bulk components for sequencing kits. You'll also ensure batch records are correctly followed and carry out testing as required.
Other responsibilities include:
- Equipment management including liaising with the manufacturer
- Continuous improvement and troubleshooting
- Production data tracking
- Updating BPs and item specifications
- Raising Change Note, Deviation, CAPA and Non-conformance
- General lab maintenance
- Batch records review
What We're Looking For...
We'll expect you to have relevant laboratory experience, ideally within a chemistry, biochemistry or pharmaceutical environment or in large scale protein, DNA, or chemicals processing. You should have a working knowledge of chemical, biochemical or molecular biology techniques as appropriate for the specific area and be familiar with GMP and GLP. Knowledge of continuous improvement methodologies would also be beneficial.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Skills Required
- BSc or equivalent relevant experience
- Relevant laboratory experience in chemistry, biochemistry, pharmaceutical or large-scale protein/DNA/chemical processing
- Working knowledge of chemical, biochemical or molecular biology techniques
- Familiarity with GMP and GLP
- Experience with batch records, quality documentation and raising Change Note/Deviation/CAPA/Non-conformance
- Knowledge of continuous improvement methodologies (e.g., Lean/Six Sigma)
- Good organizational skills, attention to detail, ability to work under pressure and team orientation
Oxford Nanopore Technologies Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Oxford Nanopore Technologies and has not been reviewed or approved by Oxford Nanopore Technologies.
-
Fair & Transparent Compensation — Pay is considered good to above average across many roles, with employer-provided ranges visible for several U.S. commercial and applications positions and company materials emphasizing market‑competitive base pay. Commercial and some senior technical posts, particularly in the U.S., are positioned as competitive and often paired with strong variable components.
-
Equity Value & Accessibility — All‑employee share plans in the UK and a U.S. employee stock purchase plan indicate broad access to equity as part of total reward. Company communications highlight attractive bonus and share plans that add meaningful upside beyond base pay.
-
Healthcare Strength — U.S. roles indicate strong health insurance and core protections, while official materials and country overviews reference private medical coverage and wellbeing support. These elements position the health package as a notable strength alongside cash compensation.
Oxford Nanopore Technologies Insights
What We Do
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
